Isaac Erbele, MD<p>This article on <a href="https://fediscience.org/tags/CochlearImplant" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CochlearImplant</span></a> argues postop antibiotics do not meaningfully change post-op infection rates within 2y of surgery.</p><p>I included it in our <a href="https://fediscience.org/tags/otology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>otology</span></a>/ <a href="https://fediscience.org/tags/neurotology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>neurotology</span></a> journal club tomorrow because it argues for a different position than what I do. Minor quibbles aside, I found the article convincing. Particularly during a post- <a href="https://fediscience.org/tags/COVID" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID</span></a> abx shortage, I think I have to abandon postop abx except in select otology cases.</p><p><a href="https://fediscience.org/tags/MedMastodon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MedMastodon</span></a></p><p><a href="https://journals.sagepub.com/doi/10.1177/01945998221082530" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">journals.sagepub.com/doi/10.11</span><span class="invisible">77/01945998221082530</span></a></p>